business
Why Savvy Investors Are Loading Up on This Beaten-Down Stock
Key takeaways
- Reuben Gregg Brewer, The Motley Fool Sun, May 10, 2026 at 1:35 AM GMT+7 3 min read MDT MMED Shares of Medtronic (NYSE: MDT) are down 40% from their 2021 high.
- Growth and profitability have both been weak spots.
- Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need.
Reuben Gregg Brewer, The Motley Fool Sun, May 10, 2026 at 1:35 AM GMT+7 3 min read MDT MMED Shares of Medtronic (NYSE: MDT) are down 40% from their 2021 high. The dividend yield is a historically high 3.6%. Although this medical device maker is deeply unloved, now could be a good time for savvy investors to start adding it to their portfolios. Here s why.
Medtronic is facing headwinds. Growth and profitability have both been weak spots. But management is attempting to improve its business performance.
Will AI create the world s first trillionaire? Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need. Continue »
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop